ADTX
ADTX
NASDAQ · Biotechnology

Aditxt Inc

$0.04
+0.02 (+117.19%)
As of Jun 23, 10:24 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +32,274.1% upside
Low Target $9.80
Average Target $13.50
High Target $19.20
Current Price $0.04
Current
$0.04
Target
$13.50
$9.80 $13.50 avg $19.20
Scenario Analysis
Bear Case
$9.80
23,401.2%
Low target
Base Case
$13.50
+32,274.1%
Avg target
Bull Case
$19.20
+45,943.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
Target vs 52W High
$13.50
-100.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%